144 related articles for article (PubMed ID: 2053766)
1. [Oncogene and patient prognosis].
Ito H; Tahara E
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1075-83. PubMed ID: 2053766
[TBL] [Abstract][Full Text] [Related]
2. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.
Tsuda H; Hirohashi S; Shimosato Y; Hirota T; Tsugane S; Yamamoto H; Miyajima N; Toyoshima K; Yamamoto T; Yokota J
Cancer Res; 1989 Jun; 49(11):3104-8. PubMed ID: 2566377
[TBL] [Abstract][Full Text] [Related]
3. Quantitative detection of amplification of proto-oncogenes in breast cancer.
Chen Y; Dong J; Lu Y; McGee JO
Chin Med J (Engl); 1995 Nov; 108(11):849-54. PubMed ID: 8585979
[TBL] [Abstract][Full Text] [Related]
4. Amplification of oncogenes and disease prognosis.
Jandrig B
Arch Geschwulstforsch; 1990; 60(2):141-8. PubMed ID: 2187430
[TBL] [Abstract][Full Text] [Related]
5. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
[TBL] [Abstract][Full Text] [Related]
6. The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review).
Field JK; Spandidos DA
Anticancer Res; 1990; 10(1):1-22. PubMed ID: 2185684
[TBL] [Abstract][Full Text] [Related]
7. [Molecular diagnosis of lung carcinoma].
Noguchi M
Rinsho Byori; 1994 Apr; 42(4):355-8. PubMed ID: 8176843
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer].
Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T
Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200
[TBL] [Abstract][Full Text] [Related]
9. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
[TBL] [Abstract][Full Text] [Related]
10. Amplification of the N-myc oncogene in an adenocarcinoma of the lung.
Saksela K; Bergh J; Nilsson K
J Cell Biochem; 1986; 31(4):297-304. PubMed ID: 3020069
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes.
Yokota J; Wada M; Yoshida T; Noguchi M; Terasaki T; Shimosato Y; Sugimura T; Terada M
Oncogene; 1988 Jun; 2(6):607-11. PubMed ID: 2838790
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
13. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
[TBL] [Abstract][Full Text] [Related]
14. BCL-1 participates in the 11q13 amplification found in breast cancer.
Theillet C; Adnane J; Szepetowski P; Simon MP; Jeanteur P; Birnbaum D; Gaudray P
Oncogene; 1990 Jan; 5(1):147-9. PubMed ID: 2181375
[TBL] [Abstract][Full Text] [Related]
15. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
16. [Cancer of the breast. Genetic alterations and prognostic factors].
Bièche I; Champème MH; Lidereau R
Pathol Biol (Paris); 1990 Sep; 38(7):727-34. PubMed ID: 2235089
[TBL] [Abstract][Full Text] [Related]
17. Oncogene amplification in neoplastic development and progression of human cancers.
Schwab M
Crit Rev Oncog; 1990; 2(1):35-51. PubMed ID: 2091749
[TBL] [Abstract][Full Text] [Related]
18. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
19. [Oncogenes in human gastric carcinoma].
Tahara E
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2149-55. PubMed ID: 2544146
[TBL] [Abstract][Full Text] [Related]
20. Proto-oncogene amplification and human breast tumor phenotype.
Adnane J; Gaudray P; Simon MP; Simony-Lafontaine J; Jeanteur P; Theillet C
Oncogene; 1989 Nov; 4(11):1389-95. PubMed ID: 2554239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
